Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro Kiran Kumar R. MangalpallyAlan Siqueiros-GarciaSasidhar Guthikonda OriginalPaper 26 May 2010 Pages: 251 - 262
An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481–The Home INR Study (THINRS) Rowena J. DolorR. Lynne Ruybalidfor the THINRS Site Investigators OriginalPaper 14 July 2010 Pages: 263 - 275
Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period Joo Heung YoonRobert W. YehIk-Kyung Jang OriginalPaper 07 May 2010 Pages: 276 - 280
Relationship between proteinuria and venous thromboembolism Shumei KatoSvetlana ChernyavskyJames F. Winchester OriginalPaper 16 February 2010 Pages: 281 - 285
Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience H. N. Abdel-RazeqS. B. HijjawiB. A. Ababneh OriginalPaper 02 February 2010 Pages: 286 - 293
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism Daniela PoliElisa GrifoniMassimo Miniati OriginalPaper 16 February 2010 Pages: 294 - 299
Lonomia obliqua venomous secretion induces human platelet adhesion and aggregation Markus BergerJosé Reck JrJorge A. Guimarães OriginalPaper 16 February 2010 Pages: 300 - 310
Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo Roman KotlínZuzana ReicheltováJan Evangelista Dyr OriginalPaper 18 July 2010 Pages: 311 - 318
Poor response to clopidogrel: current and future options for its management Gianluca CampoLuca FiletiRoberto Ferrari OriginalPaper 16 February 2010 Pages: 319 - 331
Bleeding associated with current therapies for acute coronary syndrome: What are the mechanisms? Matthew A. CavenderSunil V. Rao OriginalPaper 13 May 2010 Pages: 332 - 339
Malignancy and hypercoagulability: a two-way association revisited Elie G. AounKhaled M. MusallamAli T. Taher Letter 20 February 2010 Pages: 340 - 341
Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation Giuseppe De LucaC. Michael GibsonArnoud W. J. van’t Hof OriginalPaper 08 March 2010 Pages: 342 - 346
Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention Dariusz DudekTomasz RakowskiJacek S. Dubiel OriginalPaper 07 April 2010 Pages: 347 - 353
Validity of current recommendation for peri-operative interruption of warfarin in Asians Sei Keng KohHeng Joo NgLai Heng Lee OriginalPaper 16 April 2010 Pages: 354 - 357
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction John F. CarlquistBenjamin D. HorneJeffrey L. Anderson OriginalPaper 25 May 2010 Pages: 358 - 364
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery disease Andy TsapakiApostolos ZaravinosDemetrios A. Spandidos OriginalPaper 03 July 2010 Pages: 365 - 371
Architecture of the thrombi removed from coronary artery bypass grafts in a patient with acute myocardial infarction Grzegorz MarekAnna Kablak-ZiembickaAnetta Undas OriginalPaper 25 February 2010 Pages: 372 - 374
Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia Tia L. CorbettKathy S. ElherCandice L. Garwood OriginalPaper 23 June 2010 Pages: 375 - 377
A clinical cardiology perspective of thrombophilias Richard C. Becker OriginalPaper 14 August 2010 Pages: 378 - 389